Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution - 2Home Remodel Administrations: Change Your Residing Space
- 3Watch China's Shenzhou 22 rescue ship arrive at Tiangong space station (video)
- 4Pedal Power: Divulging Well known Bike Brands for Each Cyclist
- 5Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday
- 5 Critical Rules For Business Regulation Chiefs
- Surveys of Thrillers That Re-imagined the Class
- Analysis-From 'Icarus bug' to flawed panels: Airbus counts cost of relying on single model
- Early diagnosis leads King Charles to scale back cancer treatment in the new year
- FBI arrests Brian Cole Jr. in Jan. 6 pipe bomb investigation, ending 5-year hunt
- Happy with Running Shoes for 2024
- The Most Encouraging New companies to Look Out For
- Step by step instructions to Explore Assessment Ramifications of Disc Rates
- Best Wellness Tracker Keep You On target
